BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36670487)

  • 1. Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon.
    Teaw S; Gupta A; Williams A; Wilson FP; Sumpio BJ; Sumpio BE; Hinchcliff M
    Arthritis Res Ther; 2023 Jan; 25(1):10. PubMed ID: 36670487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis.
    Pauling JD; Reilly E; Smith T; Frech TM
    J Rheumatol; 2019 Oct; 46(10):1326-1334. PubMed ID: 30824643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Laser Speckle Contrast Imaging to Assess Digital Microvascular Function in Primary Raynaud Phenomenon and Systemic Sclerosis: A Comparison Using the Raynaud Condition Score Diary.
    Pauling JD; Shipley JA; Hart DJ; McGrogan A; McHugh NJ
    J Rheumatol; 2015 Jul; 42(7):1163-8. PubMed ID: 26034146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.
    Wilkinson JD; Leggett SA; Marjanovic EJ; Moore TL; Allen J; Anderson ME; Britton J; Buch MH; Del Galdo F; Denton CP; Dinsdale G; Griffiths B; Hall F; Howell K; MacDonald A; McHugh NJ; Manning JB; Pauling JD; Roberts C; Shipley JA; Herrick AL; Murray AK
    Arthritis Rheumatol; 2018 Jun; 70(6):903-911. PubMed ID: 29457381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.
    Pauling JD; Reilly E; Smith T; Frech TM
    Arthritis Care Res (Hoboken); 2019 Aug; 71(8):1119-1126. PubMed ID: 30133174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.
    Motegi S; Yamada K; Toki S; Uchiyama A; Kubota Y; Nakamura T; Ishikawa O
    J Dermatol; 2016 Jan; 43(1):56-62. PubMed ID: 26173902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital vasculopathy: A systematic literature review.
    Pauling JD; Hackett N; Guida A; Merkel PA
    Semin Arthritis Rheum; 2020 Oct; 50(5):1114-1130. PubMed ID: 32920325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A; Abou-Raya S; Helmii M
    J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser Doppler imaging evaluation of nitroglycerin patch application in systemic sclerosis patients.
    Pintea Bentea G; Wauters A; Wautrecht JC; Cogan E
    Vasc Med; 2020 Dec; 25(6):559-568. PubMed ID: 32990196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of a home-based program for hands in patients with systemic sclerosis.
    Landim SF; Bertolo MB; Marcatto de Abreu MF; Del Rio AP; Mazon CC; Marques-Neto JF; Poole JL; de Paiva Magalhães E
    J Hand Ther; 2019; 32(3):313-321. PubMed ID: 29198478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis.
    Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE
    Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiac magnetic resonance in the diagnosis of cardiac Raynaud phenomenon in a patient with systemic sclerosis: case report and review of literature.
    Quarta S; Galea N; Gigante A; Romaniello A; Rosato E; Carbone I
    Expert Rev Clin Immunol; 2016; 12(3):251-5. PubMed ID: 26692357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Raynaud's phenomenon by
    Pavlov-Dolijanovic S; Petrovic N; Vujasinovic Stupar N; Damjanov N; Radunovic G; Babic D; Sobic-Saranovic D; Artiko V
    Rheumatol Int; 2016 Dec; 36(12):1683-1688. PubMed ID: 27783160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.
    Bissell LA; Abignano G; Emery P; Del Galdo F; Buch MH
    BMC Musculoskelet Disord; 2016 Aug; 17(1):342. PubMed ID: 27526772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.
    Correa MJ; Andrade LE; Kayser C
    Arthritis Res Ther; 2010; 12(4):R157. PubMed ID: 20696074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud phenomenon and digital ulcers in systemic sclerosis.
    Hughes M; Allanore Y; Chung L; Pauling JD; Denton CP; Matucci-Cerinic M
    Nat Rev Rheumatol; 2020 Apr; 16(4):208-221. PubMed ID: 32099191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire.
    Pauling JD; Yu L; Frech TM; Herrick AL; Hummers LK; Shah AA; Denton CP; Saketkoo LA; Withey J; Khanna D; Domsic RT
    Rheumatology (Oxford); 2024 May; 63(5):1281-1290. PubMed ID: 37481713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma urotensin II levels in primary Raynaud's phenomenon and systemic sclerosis.
    Gözel N; Karataş A; Yardım M; Kınacı MS; Ulu R; Demircan F; Kılınç F; Öz B; Dönder E; Aydın S; Koca SS
    Turk J Med Sci; 2017 Dec; 47(6):1687-1692. PubMed ID: 29306224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.